Skip Navigation

Biodefense and Emerging Infectious Diseases

Skip Content Marketing
  • Share this:
  • submit to facebook
  • Tweet it
  • submit to reddit
  • submit to StumbleUpon
  • submit to Google +

Questions and Answers
Research Before 2011

Click to expand or collapse content.

Open All

1. What is NIAID’s role in biodefense and emerging infectious disease research?

 

2. How do NIAID activities fit into the larger national strategy to protect the public against bioterrorism?

 

3. Has the NIAID role in supporting biodefense and emerging infectious disease research changed over the last decade?

 

4. What have been some of the most important achievements resulting from NIAID investment in research on biodefense and emerging infectious diseases?

 

5. How does basic research get translated into medical products for the public?

 

6. How has NIAID contributed to the nation’s research infrastructure and resources for biodefense and emerging infectious diseases?

 

7. How has biodefense and emerging infectious diseases research benefited research on other diseases?

 

8. What specific biodefense-related research advances have had crossover application to other areas of research?

 

9. How does NIAID determine which pathogens are priorities for research funding?

 

10. Looking ahead, what are the NIAID’s highest research priorities related to biodefense and emerging infectious diseases?

Last Updated October 28, 2011

Last Reviewed October 04, 2011